COVID-19 vaccination programme weekly update: 11 May 2021

Our National Vaccination Strategy was published on 11 January and is based on the detailed planning NHS Wales had been doing. Our strategy is focused on 3 key areas:

• Our priorities – we continue to work closely with the UK Government on supply. Based on what we know about supply and the priority cohorts set by the JCVI, we have set key milestones.
• Our vaccination infrastructure - making sure that people can access their vaccination offer - the places to go to get vaccinated, people to give the vaccination and the appointment and digital recording and reporting system set up.
• Keeping up to date and informed about the vaccination programme - we are committed to providing information to keep everyone in Wales updated about the vaccination programme.

An update to our National Strategy was published on 26 February 2021 to reflect on progress and provide further information about our current and future priorities.

Our priority list of people to receive the vaccine has been agreed by endorsing the UK’s independent Joint Committee on Vaccination and Immunisation (JCVI). The same priority list is being followed by all four nations in the UK and has the support of all 4 Chief Medical Officers (CMOs) within the UK.

As set in the progress section below, we have completed the first phase of the programme: 

• all older person care home residents and staff
• frontline health and social care staff
• those 50 years of age and over
• the clinically extremely vulnerable individuals
• those with underlying health conditions with put them at higher risk of serious disease and mortality

We are now in phase 2 of the programme. Subject to supply, our aim is to offer the vaccine to all eligible adults in Wales by the end of July. 

As we continue to operate on the principle of no one left behind, the NHS will go back and offer those in priority groups 1-9 who for various reason have not yet taken up their offer. 

That means, we are now vaccinating:

• everyone aged 30 to 39
• remaining adults aged 40-49
• household contacts of severely immunosuppressed 
• anyone who, for whatever reason, was missed in priority groups 1-9, so that no one is left behind

Our second dose programme is running substantively alongside our first dose programme. The second dose is essential for longer term protection so it’s really important that second dose offers are taken up.

Our infrastructure has been built from the ground up and is a blended delivery model. This is aimed at providing a mix of sites in order to maximise speed of roll out, ensure safety, meet the needs of the characteristics of the vaccines, be as conveniently located as possible and, importantly make sure we give equitable access across the country and all communities.

During the past week vaccinations were being administered in 448 locations across Wales, including:

• 54 mass vaccination centres
• 338 general practice locations
• 12 pharmacies
• 24 hospital locations
• and there were 19 mobile teams operating

Achievement of markers and milestones

We have completed phase 1 of our programme, which includes 2 milestones. 

Milestone 1

In our Vaccination Strategy we said that subject to supply we would: 

Offered the vaccine to all individuals in cohorts 1–4 by mid February. That includes all older person care home residents and staff; frontline health and social care staff; those 70 years of age and over; and clinically extremely vulnerable individuals.

We confirmed on 12 February that we had achieved this milestone.  

We also outlined 3 markers to deliver as part of our journey to achieving milestone 1 by mid-February:  

• marker 1 was to have offered a first dose of the vaccine to all frontline Welsh Ambulance Trust staff by 18 January
• marker 2 was to have offered the vaccine to all older person care home residents and staff by the end of January
• marker 3 was to have 250 GP practices deploying the vaccine by the end of January

These first groups are now being offered their second dose of the vaccine, which is important for longer term protection. 90% of care home residents and almost 80% of care home staf have now received their full course of the vaccine.

Milestone 2

We said we would, subject to supply: 

Offered the vaccine to all individuals in cohorts 1-9 by mid April. That includes all those aged 50 and over.
We achieved this milestone on 4 April. 

We also outlined 3 markers we expected to achieve during milestone 2 by mid-April:   

• 1 million vaccine doses administered by 7 March.  This was achieved ahead of the target date on 27 February
• 1 million first doses administered by 14 March. This was achieved ahead of the target date on 9 March.
• 1.5 million doses administered during Milestone 2. This was achieved

In summary:

• all those in priority groups 1-9 have been offered the vaccine and those in priority group 10 are being offered the vaccine
• up-take is very high:
  • for first doses - over 95% for first doses for some groups, including care home residents, and those aged 75 and over, meaning our most vulnerable groups of the population are fully protected
  • for second dose - already over 90% for some groups, including care home residents and those aged 75 and over
• so far 1,948,683 people have received their first dose of the vaccine in Wales
• 854,441 people have received their full course of vaccine. In total, more than 2.8 million vaccines have been administered
• 77% of the 40-49 cohort have received a first dose and 52% of the 30-39 have received a first dose
• we are maintaining the best first dose vaccination rate in the UK, as the following 7 day rolling average chart from 9 May shows, and a greater proportion of people in Wales have had both doses of the vaccine than in any other part of the UK
• overall, 77% of our adult population have had a first dose and one in three adults in Wales have completed the two-dose course

Image

Protecting the vulnerable has always been at the heart of our response and the speed of our roll out and our high take up rate means we are well on our way towards that important goal. There are always plans in place to ensure that no one is left behind, so it is never too late for someone in the first priority groups to come forward for their vaccination.

Phase 2 of our Vaccination Programme is underway and our current priority is milestone 3 in our Strategy. 
We have said, subject to supply, it is our aim to offer everyone in the current 10 priority groups their first dose of the vaccine by the end of July.  

We are continuing to quickly work our way through the age groups in priority group 10 across Wales. 77% of people aged 40-49 have received their first dose. 

The vaccine used in the mass vaccination centres will vary, however, people will be invited to a vaccination appointment where the vaccine used is appropriate for their age or clinical circumstances. The excellent progress being made by the vaccination programme means all health boards are now vaccinating people under 40, this means vaccination centres will be predominantly using the Pfizer BioNTech or Moderna vaccines.

People’s safety always comes first. We will only use vaccines where it is safe to do so and the benefits continue to outweigh the risks. We are confident in the vaccines and certain that we must keep momentum. Alongside Public Health Wales and NHS Wales, we are working with other agencies to continually monitor vaccine safety and will keep this issue under close review. 

On Friday 7 May, the Joint Committee on Vaccination and Immunisation (JCVI) updated their expert advice and, as a precautionary measure, those under 40 years of age with no clinical risk factors who are not yet vaccinated should be offered an alternate to AstraZeneca. We have immediately implemented this change into our programme, adhering to the latest expert information. In line with updated JCVI advice, health boards will make the appropriate vaccine available at the right time for individuals, particularly those under 40 years of age who have not yet received a first dose.  

JCVI’s advice is based on a consideration of the specific UK situation, including current epidemiology, benefit-risk profile by age, modelling predictions on future disease trends and current forecasts on vaccine supply.

Our current vaccine supply and rate of infection means we are able to take this precautionary step and we do not envisage this will lead to a delay to the roll out of our vaccine programme in Wales. We are still working towards the third milestone set out in our Strategy, which is to offer a vaccine to everyone aged 18 and over by 31st July 2021.

The JCVI advises that there continues to be no concerning safety signals for this extremely rare adverse event following a second dose of AstraZeneca vaccine. 

Everybody who has already had a first dose of the AstraZeneca vaccine should be reassured that they should receive a second dose of the same brand, irrespective of age, in line with JVCI advice. Medical exemptions may apply to a very small minority, for example the very small number of people who experienced blood clots with low platelet counts following their first vaccination or have experienced a severe allergic reaction to their first dose.

The AstraZeneca vaccine has already saved thousands of lives and remains safe and effective for the majority of the population. Over 1.2million people have received the AstraZeneca vaccine in Wales since January, with very few cases of the rare clotting with thrombocytopenia event.

Vaccines remain the best way out of this pandemic and provide strong protection against COVID-19 - it is important that when people are called forward, they should get their vaccination. 

It is important that we maintain the current high-levels of vaccine uptake to keep Wales safe. Every dose administered and every person protected really does make a difference. The vaccines are safe and effective and we urge everyone to take up their offer when it is their turn. Your second dose of vaccine is important for longer lasting protection against COVID-19.

Public Health Wales has helpful FAQs on their website about the vaccine and safety, they are also publishing daily and weekly surveillance data releases.

A range of information on our vaccination programme is available on our website, including guidance published relating to the priority groups. 

Welsh Government statisticians are also publishing some of the more operational statistics attached to the programme each week.